Viewing Study NCT01537432

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 9:54 PM

Ignite Modification Date: 2025-12-25 @ 7:33 PM

Study NCT ID: NCT01537432

Status: COMPLETED

Last Update Posted: 2016-01-05

First Post: 2012-02-17

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Sponsor: Novartis Pharmaceuticals

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module